Neanderthal genes unearthed in modern humans
On Jan. 29, 2014, Neanderthal genes were unearthed in modern humans by University of Washington scientists Benjamin Vernot…
On Jan. 29, 2014, Neanderthal genes were unearthed in modern humans by University of Washington scientists Benjamin Vernot…
On Jan. 24, 2014, InBios announced that it had licensed a U.S. Department of Agriculture (USDA) West Nile…
On Jan. 23, 2014, the National Institutes of Health (NIH) awarded the Benaroya Research Institute at Virginia Mason…
On Dec. 3, 2013, Juno Theraputics, a biotechnology company focused on bringing forward novel immunotherapies for cancer, was…
On Nov. 9, 2013, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington launched…
On Jul. 23, 2013, Matrical Bioscience announced it has had been acquired by Chelmsford, Massachusetts-based Brooks Automation for…
On Jun. 25, 2013, NanoString Technologies launched an initial public offering at $10.00 per share and raised $54…
On May 14, 2013, a University of Washington led team announced that DNA analysis had unearthed the origins…
On Apr. 17, 2013, researchers from the University of Washington, Broad Institute of Harvard and M.I.T. announced that…
On Mar. 27, 2013, researchers at the University of British Columbia and Canada’s Michael Smith Genome Sciences Centre…
On Nov. 8, 2012, Atossa Genetics, the Breast Health Company completed its IPO with gross proceeds of $4…
On Apr. 3, 2012, the Washington State Secretary of Health declared a pertussis epidemic. By June 16, the…
On Mar. 21, 2012, the University of Washington Medical Center became the first in Pacific Northwest to discharge…
On Jan. 31, 2012, the FDA approved a KALYDECO (ivacaftor), University of Washington-tested drug to treat the genetic…
On Jan. 1, 2012 Alan Aderem, Ph.D., became president of Seattle BioMed, now known as Center for Infectious…
On Aug. 30, 2011, Amnis, a Seattle-based manufacturer of advanced cell imaging systems, announced the company had been…
On Aug. 19, 2011, the U.S. Food and Drug Administration (FDA) approved Seattle Genetics’ Adcetris (brentuximab vedotin), making…
On Feb. 22, 2011, Foster City, Calif-based Gilead Sciences and Calistoga Pharmaceuticals announced Gilead’s acquisition of Calistoga for…
In 2011, the Pacific Northwest Diabetes Research Institute began clinical trials on antioxidant drug treatments on volunteers from…
On Dec. 3, 2010, Banglore, India-based Opto Circuits announced completion of its merger with Bothell-based Cardiac Science Corp….
On Oct. 28, 2010, Emergent BioSolutions announced it had completed the acquisition of Seatte-based Trubion Pharmaceutical for upfront…
On Oct. 12, 2010, HaloSource completed its IPO on the London Stock Exchange and raised $50 million in…
On Oct. 12, 2010, Bristol-Myers Squibb Company announced it had completed its acquisition of ZymoGenetics. Bristol-Myers Squibb initiated…
On Sept. 15, 2010, Pacific Northwest Diabetes Research Institute appointed Jack Faris, Ph.D., as Chief Executive Officer. Previously,…
On Aug. 12, 2010, OriGene Technologies based in Rockville, Maryland, announced the acquisition of Blue Heron Biotechnology, a…
On Jul. 22, 2010, MDRNA announced that MDRNA shareholders approved the issuance of shares of MDRNA common stock…
On Jun. 30, 2010, SonoSite acquired VisualSonics, a Toronto-based company focused on ultra high-frequency micro-ultrasound technology, for $67.9…
On Nov. 11, 2009, the Pacific Northwest Diabetes Research Institute announced the appointment of William Hagopian, M.D., Ph.D.,…
On Oct. 8, 2009, Omeros Corp. launched an initial public offering at $10.00 per share and raised $62.1…
On Apr. 15, 2009, Oregon Health & Science University (OHSU) and the University of Washington (UW), along with…